Myriad Genetics unveils FirstGene Multiple Prenatal Screen at Washington D.C. symposium

Myriad Genetics unveils FirstGene Multiple Prenatal Screen at Washington D.C. symposium
Myriad Genetics unveils prenatal screen

Myriad Genetics is set to introduce the FirstGene Multiple Prenatal Screen at an industry-hosted symposium in Washington, D.C. on Sunday, May 3.

The session will focus on how this single-draw prenatal test can assess multiple genetic risks simultaneously. Myriad Genetics positions the product as a technological advancement in prenatal screening, highlighting the integration of various technologies for comprehensive genetic risk detection. Attendees can expect insights into the benefits of streamlined testing through emerging medical technology.

Earlier this year, Myriad Genetics was ranked by Forbes among America's best employers for company culture in 2026 based on employee feedback. The company's workplace recognition follows a period of expansion in its genetic testing offerings. Myriad continues to develop new products addressing reproductive health and genetic risk assessment.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.